{'url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2019/pembrolizumab-merkel-cell-carcinoma-fda-approval', 'method': 'GET', 'status': 200, 'response_url': 'https://www.cancer.gov/news-events/cancer-currents-blog/2019/pembrolizumab-merkel-cell-carcinoma-fda-approval', 'timestamp': 1711313091.9312475}